Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Israel
  4. TEL AVIV STOCK EXCHANGE
  5. Evogene Ltd.
  6. Summary
    EVGN   IL0011050551

EVOGENE LTD.

(EVGN)
  Report
Delayed Quote. Delayed TEL AVIV STOCK EXCHANGE - 06/22 10:24:53 am
1115 ILa   -5.03%
06/06EVOGENEá : Corporate Presentation
PU
04/19EVOGENEá : Canonic Company Presentation
PU
04/19EVOGENEá : AgPlenus Company Presentation
PU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsRevisions 
Quotes 5-day view   Delayed Quote. Delayed Tel Aviv Stock Exchange
06/16/2021 06/17/2021 06/20/2021 06/21/2021 06/22/2021 Date
1172(c) 1202(c) 1179(c) 1174(c) 1115 Last
65 331 59 085 17 427 38 513 112 346 Volume
-0.68% +2.56% -1.91% -0.42% -5.03% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 0,50 M - -
Net income 2021 -29,5 M - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Sales 2022 1,40 M - -
Net income 2022 -31,2 M - -
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 145 M 146 M -
Capi. / Sales 2021 290x
Capi. / Sales 2022 104x
Nbr of Employees 131
Free-Float 89,4%
More Financials
Company
Evogene Ltd. (Evogene) is a biotechnology company for the improvement of crop productivity. The Company is engaged in developing seed traits for improved yield and abiotic stress tolerance, seed traits for biotic stress resistance, herbicides and bio-stimulants. The Company operates a seed business under its subsidiary Evofuel Ltd. (Evofuel). It operates through two segments. Its Evogene segment develops seed... 
Sector
Pharmaceuticals
Calendar
08/12Earnings Release
More about the company
All news about EVOGENE LTD.
06/06EVOGENEá : Corporate Presentation
PU
04/19EVOGENEá : Canonic Company Presentation
PU
04/19EVOGENEá : AgPlenus Company Presentation
PU
04/19EVOGENEá : Biomica Company Presentation
PU
04/19EVOGENEá : Lavie Bio Company Presentation
PU
04/19EVOGENEá : Corporate Presentation
PU
04/13EVOGENEá : Biomica Says Biotherapeutic Drug Candidate Showed 'Significantly Incr..
MT
04/05EVOGENEá : Files Annual Report for the Year Ended December 31, 2020
AQ
03/25TIKUN OLAM CANNBIT PHARMACEUTICALSá : Canonic of Evogene Group and Tikun Olam (I..
AQ
03/25Evogene Subsidiary and Tikun Olam-Cannbit Pharmaceuticals Sign Production Agr..
MT
03/25EVOGENEá : Canonic of Evogene Group and Tikun Olam (Israel)-Cannbit, sign produc..
PR
03/17EVOGENEá : Plastomics and Evogene's Ag-Seed division enter a collaborative agree..
AQ
03/17EVOGENEá : Plastomics and Evogene's Ag-Seed division enter a collaborative agree..
PU
03/17EVOGENEá : Signs Deal With Plastomics Targeting Insect Control Traits for Soybea..
MT
03/17EVOGENEá : Plastomics and Evogene's Ag-Seed division enter a collaborative agree..
PR
More news
News in other languages on EVOGENE LTD.

- No features available -

More news
Analyst Recommendations on EVOGENE LTD.
More recommendations
Chart EVOGENE LTD.
Duration : Period :
Evogene Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EVOGENE LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishBullish
Income Statement Evolution
Managers and Directors
NameTitle
Ofer Haviv President & Chief Executive Officer
Dorit Kreiner Chief Financial Officer
Martin S. Gerstel Chairman
Mark Kapel Executive Vice President-Technology
Eyal Emmanuel Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
EVOGENE LTD.-23.96%145
JOHNSON & JOHNSON4.10%431 456
ROCHE HOLDING AG12.99%328 650
PFIZER, INC.7.09%220 661
NOVARTIS AG3.00%210 615
ABBVIE INC.7.07%202 639